{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T19:34:14Z","timestamp":1782416054630,"version":"3.54.5"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Department of Public Health Science College of Medicine"},{"DOI":"10.13039\/100008321","name":"Penn State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The prevalence of Babesia coinfecting tick-borne zoonoses and mortality outcomes are not fully elucidated. The objective of the present study was to determine babesiosis coinfection prevalence rates and estimate the association with severe disease and mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We queried the TriNetX database between 2015 and 2022 for patients with babesiosis. The prevalence of Babesia coinfecting tick-borne zoonoses was estimated. The analysis focused on babesiosis coinfection with Borrelia burgdorferi, ehrlichiosis, and anaplasmosis. The exposure was coinfection, and the control group was the Babesia-only group. The primary outcome was 90-day mortality from the diagnosis of Babesia. Secondary outcomes were prevalence of coinfection, association of coinfection with acute respiratory distress syndrome, multiorgan failure, and disseminated intravascular coagulation. A multivariable logistic regression model was employed to estimate the disease severity and mortality risk associated with coinfections.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 3521 patients infected with Babesia, the mean age (SD) was 56 (18) years, 51% were male, and 78% were White. The frequency of overall malignancies, lymphomas, and asplenia was 19%, 2%, and 2%, respectively. Temporal distribution of coinfections followed the overall babesiosis pattern, peaking in the summer months. The prevalence of 1 or more coinfections was 42% (95% CI, 40%\u201343%). The rate of coinfection with Borrelia burgdorferi was the highest at 41% (95% CI, 39%\u201342%), followed by ehrlichiosis at 3.7% (95% CI, 3.1%\u20134.4%) and anaplasmosis at only 0.3% (95% CI, 0.2%\u20130.6%). Doxycycline was more likely to be prescribed in the coinfection group than the Babesia-only group (25% vs 18%; P &amp;lt; .0001). Overall, 90-day mortality was 1.4% (95% CI, 1.0%\u20131.8%). After adjusting for potential confounding factors, compared with the babesiosis-only group, the likelihood of 90-day mortality was lower in the coinfection group (adjusted odds ratio, 0.43; 95% CI, 0.20\u20130.91). Severe disease did not differ significantly between the 2 groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In this extensive study of &amp;gt;3000 patients with babesiosis in the United States, 4 in 10 patients had coinfecting tick-borne zoonoses. The prevalence rates of coinfection were highest with Borrelia burgdorferi, followed by ehrlichiosis, and lowest with anaplasmosis. Coinfection with other tick-borne infections was not associated with severe disease. It is plausible that this finding is due to the likelihood of treatment of coinfections with doxycycline. Future studies are needed to investigate the possible therapeutic benefits of doxycycline in babesiosis patients as, to date, no trials with doxycycline have been conducted in human patients with Babesia infections.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofae504","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T16:24:59Z","timestamp":1728404699000},"source":"Crossref","is-referenced-by-count":10,"title":["Beyond Human Babesiosis: Prevalence and Association of <i>Babesia<\/i> Coinfection with Mortality in the United States, 2015\u20132022: A Retrospective Cohort Study"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1565-5731","authenticated-orcid":false,"given":"Paddy","family":"Ssentongo","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and Epidemiology, Department of Medicine, Penn State Health Milton S. Hershey Medical Center , Hershey, Pennsylvania ,","place":["USA"]},{"name":"Department of Public Health Sciences, Penn State College of Medicine , Hershey, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Venugopal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Penn State Health Milton S. Hershey Medical Center , Hershey, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Penn State College of Medicine , Hershey, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernon M","family":"Chinchilli","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Penn State College of Medicine , Hershey, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djibril M","family":"Ba","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Penn State College of Medicine , Hershey, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"2024102921271857100_ofae504-B1","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3390\/pathogens10111430","article-title":"Ticks, human babesiosis and climate change","volume":"10","author":"Gray","year":"2021","journal-title":"Pathogens"},{"key":"2024102921271857100_ofae504-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13567-020-00802-z","article-title":"Climate change implications for the distribution of the babesiosis and anaplasmosis tick vector, Rhipicephalus (Boophilus) microplus","volume":"51","author":"Marques","year":"2020","journal-title":"Vet Res"},{"key":"2024102921271857100_ofae504-B3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3201\/eid2802.210213","article-title":"Epidemiology of hospitalized patients with babesiosis, United States, 2010\u20132016","volume":"28","author":"Bloch","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"2024102921271857100_ofae504-B4","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/pathogens10111447","article-title":"The global emergence of human babesiosis","volume":"10","author":"Kumar","year":"2021","journal-title":"Pathogens"},{"key":"2024102921271857100_ofae504-B5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pt.2017.12.006","article-title":"The blacklegged tick, Ixodes scapularis: an increasing public health concern","volume":"34","author":"Eisen","year":"2018","journal-title":"Trends Parasitol"},{"key":"2024102921271857100_ofae504-B6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijpara.2018.11.007","article-title":"Human babesiosis","volume":"49","author":"Krause","year":"2019","journal-title":"Int J Parasitol"},{"key":"2024102921271857100_ofae504-B7","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/319742","article-title":"Severe babesiosis in long island: review of 34 cases and their complications","volume":"32","author":"Hatcher","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2024102921271857100_ofae504-B8","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/jama.2016.2884","article-title":"Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review","volume":"315","author":"Sanchez","year":"2016","journal-title":"JAMA"},{"key":"2024102921271857100_ofae504-B9","doi-asserted-by":"crossref","first-page":"e0199644","DOI":"10.1371\/journal.pone.0199644","article-title":"Using citizen science to describe the prevalence and distribution of tick bite and exposure to tick-borne diseases in the United States","volume":"13","author":"Nieto","year":"2018","journal-title":"PLoS One"},{"key":"2024102921271857100_ofae504-B10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1128\/CMR.00011-06","article-title":"Coinfections acquired from Ixodes ticks","volume":"19","author":"Swanson","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"2024102921271857100_ofae504-B11","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/pathogens11111309","article-title":"Transmission cycle of tick-borne infections and co-infections, animal models and diseases","volume":"11","author":"Rocha","year":"2022","journal-title":"Pathogens"},{"key":"2024102921271857100_ofae504-B12","doi-asserted-by":"crossref","first-page":"101637","DOI":"10.1016\/j.ttbdis.2020.101637","article-title":"Prevalence of single and coinfections of human pathogens in Ixodes ticks from five geographical regions in the United States, 2013\u20132019","volume":"12","author":"Lehane","year":"2021","journal-title":"Ticks Tick Borne Dis"},{"key":"2024102921271857100_ofae504-B13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pt.2015.09.008","article-title":"Coinfection by Ixodes tick-borne pathogens: ecological, epidemiological, and clinical consequences","volume":"32","author":"Diuk-Wasser","year":"2016","journal-title":"Trends Parasitol"},{"key":"2024102921271857100_ofae504-B14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/pathogens11030282","article-title":"Human co-infections between Borrelia burgdorferi sl and other Ixodes-borne microorganisms: a systematic review","volume":"11","author":"Boyer","year":"2022","journal-title":"Pathogens"},{"key":"2024102921271857100_ofae504-B15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/infdis\/152.3.473","article-title":"Serological evidence for simultaneous occurrences of Lyme disease and babesiosis","volume":"152","author":"Benach","year":"1985","journal-title":"J Infect Dis"},{"key":"2024102921271857100_ofae504-B16","author":"Bloch"},{"key":"2024102921271857100_ofae504-B17","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1086\/339813","article-title":"Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and lyme disease","volume":"34","author":"Krause","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2024102921271857100_ofae504-B18","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4269\/ajtmh.17-0146","article-title":"Risk factors for severe infection, hospitalization, and prolonged antimicrobial therapy in patients with babesiosis","volume":"97","author":"Mareedu","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"2024102921271857100_ofae504-B19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1086\/317465","article-title":"Coexposure to Borrelia burgdorferi and Babesia microti does not worsen the long-term outcome of Lyme disease","volume":"31","author":"Wang","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2024102921271857100_ofae504-B20","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.1996.03530450047031","article-title":"Concurrent Lyme disease and babesiosis: evidence for increased severity and duration of illness","volume":"275","author":"Krause","year":"1996","journal-title":"JAMA"},{"key":"2024102921271857100_ofae504-B21","author":"Sweeney"},{"key":"2024102921271857100_ofae504-B22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.7326\/0003-4819-103-3-374","article-title":"Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis: demonstration of spirochetes in the myocardium","volume":"103","author":"Marcus","year":"1985","journal-title":"Ann Intern Med"},{"key":"2024102921271857100_ofae504-B23"},{"key":"2024102921271857100_ofae504-B24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","article-title":"STROBE reporting guidelines for observational studies","volume":"156","author":"Ghaferi","year":"2021","journal-title":"JAMA Surg"},{"key":"2024102921271857100_ofae504-B25","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3174\/ajnr.A4696","article-title":"ICD-10: history and context","volume":"37","author":"Hirsch","year":"2016","journal-title":"Am J Neuroradiol"},{"key":"2024102921271857100_ofae504-B26","doi-asserted-by":"crossref","first-page":"587131","DOI":"10.1155\/2015\/587131","article-title":"Human coinfection with Borrelia burgdorferi and Babesia microti in the United States","volume":"2015","author":"Knapp","year":"2015","journal-title":"J Parasitol Res"},{"key":"2024102921271857100_ofae504-B27","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/archinte.158.19.2149","article-title":"Human babesiosis in New York state: review of 139 hospitalized cases and analysis of prognostic factors","volume":"158","author":"White","year":"1998","journal-title":"Arch Intern Med"},{"key":"2024102921271857100_ofae504-B28","volume-title":"PASS 11","author":"Hintze","year":"2011"},{"key":"2024102921271857100_ofae504-B29","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S","article-title":"A simple method of sample size calculation for linear and logistic regression","volume":"17","author":"Hsieh","year":"1998","journal-title":"Stat Med"},{"key":"2024102921271857100_ofae504-B30","author":"Underwood"},{"key":"2024102921271857100_ofae504-B31","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1086\/341452","article-title":"Increased arthritis severity in mice coinfected with Borrelia burgdorferi and Babesia microti","volume":"186","author":"Moro","year":"2002","journal-title":"J Infect Dis"},{"key":"2024102921271857100_ofae504-B32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijpara.2018.06.006","article-title":"Investigating disease severity in an animal model of concurrent babesiosis and Lyme disease","volume":"49","author":"Bhanot","year":"2019","journal-title":"Int J Parasitol"},{"key":"2024102921271857100_ofae504-B33","doi-asserted-by":"crossref","first-page":"419440","DOI":"10.3389\/fimmu.2018.02891","article-title":"Age-related differential stimulation of immune response by Babesia microti and Borrelia burgdorferi during acute phase of infection affects disease severity","volume":"9","author":"Djokic","year":"2018","journal-title":"Front Immunol"},{"key":"2024102921271857100_ofae504-B34","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1128\/IAI.67.8.4143-4148.1999","article-title":"Roles of CD4+ T cells and gamma interferon in protective immunity against Babesia microti infection in mice","volume":"67","author":"Igarashi","year":"1999","journal-title":"Infect Immun"},{"key":"2024102921271857100_ofae504-B35","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1056\/NEJM200011163432004","article-title":"Atovaquone and azithromycin for the treatment of babesiosis","volume":"343","author":"Krause","year":"2000","journal-title":"N Engl J Med"},{"key":"2024102921271857100_ofae504-B36","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1111\/trf.15346","article-title":"Adjunctive treatment of clinically severe babesiosis with red blood cell exchange: a case series of nineteen patients","volume":"59","author":"Nixon","year":"2019","journal-title":"Transfusion"},{"key":"2024102921271857100_ofae504-B37","author":"Lin"},{"key":"2024102921271857100_ofae504-B38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2008.07.023","article-title":"In vitro evaluation of the growth inhibitory activities of 15 drugs against Babesia gibsoni (Aomori strain)","volume":"157","author":"Matsuu","year":"2008","journal-title":"Vet Parasitol"},{"key":"2024102921271857100_ofae504-B39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0304-4017(96)01016-3","article-title":"Prophylactic treatment of experimental canine babesiosis (Babesia canis) with doxycycline","volume":"66","author":"Vercammen","year":"1996","journal-title":"Vet Parasitol"},{"key":"2024102921271857100_ofae504-B40","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-023-01111-1","article-title":"Successful treatment with doxycycline monotherapy for human infection with Babesia venatorum (Babesiidae, Sporozoa) in China: a case report and proposal for a clinical regimen","volume":"12","author":"Huang","year":"2023","journal-title":"Infect Dis Poverty"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/10\/ofae504\/60199704\/ofae504.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/10\/ofae504\/60199704\/ofae504.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T21:27:39Z","timestamp":1730237259000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae504\/7798103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,9,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae504","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,9,27]]},"article-number":"ofae504"}}